US Broker Ratings

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 111.64% Upside in Biotech Innovation

Sana Biotechnology, Inc. (NASDAQ: SANA) presents a compelling opportunity for investors keen on the burgeoning field of biotechnology, with a standout potential upside of 111.64%. Headquartered..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Verastem, Inc. (VSTM) Stock Analysis: Biotech Innovator’s 100% Upside Potential Amid Clinical Trials

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with a remarkable potential upside of over 100%, as suggested by recent analyst ratings. This U.S.-based..

Beta Bionics, Inc. (BBNX)

⚠️ No article content returned.

..

STAAR Surgical Company (STAA) Stock Analysis: Evaluating the Healthcare Player’s Growth Potential Amidst a Volatile Market

STAAR Surgical Company (NASDAQ: STAA) stands as a prominent entity within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in Lake Forest,..

Definitive Healthcare Corp. (DH): Investor Outlook Reveals 71% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the healthcare information services industry, is garnering investor attention with its potential upside of 71.23%. Specializing in..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A High-Risk, High-Reward Play with 246% Potential Upside

Investors with an appetite for high-risk, high-reward opportunities may find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. The company, operating within the biotechnology sector, is..

REGENXBIO Inc. (RGNX)

⚠️ No article content returned.

..

Arvinas, Inc. (ARVN) Stock Analysis: Unveiling an 80% Potential Upside in Biotechnology

Arvinas, Inc. (NASDAQ: ARVN), a rising star in the biotechnology sector, offers a compelling narrative for investors seeking opportunities in healthcare innovation. The company, headquartered in..

Enhabit, Inc. (EHAB) Stock Analysis: Evaluating a 21.60% Potential Upside in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a key player in the healthcare sector specializing in home health and hospice services, presents a noteworthy case for investors considering the..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Eyeing a 34.5% Upside as Revenue Growth Soars

Theravance Biopharma, Inc. (NASDAQ: TBPH), a promising player in the biotechnology sector, is capturing investor attention with its remarkable revenue growth and a significant potential upside..

Altimmune, Inc. (ALT) Stock Analysis: Exploring a 317% Upside Potential in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, has recently captured the attention of investors with its significant potential upside of 317.37%. Headquartered in Gaithersburg, Maryland,..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: 124% Potential Upside Ignites Investor Interest

Tyra Biosciences, Inc. (NASDAQ: TYRA), a promising clinical-stage biotechnology company situated in the healthcare sector, has captured the attention of investors with an impressive potential upside..

Kura Oncology, Inc. (KURA) Investor Outlook: Analysts Eye a 165% Upside Potential

Kura Oncology, Inc. (KURA) is gaining traction among investors, buoyed by an impressive potential upside of 165.75% as derived from current analyst ratings. This biopharmaceutical company,..

Auna SA (AUNA) Stock Analysis: Exploring a Promising 118.51% Potential Upside

Auna S.A. (AUNA), a significant player in the healthcare sector, is capturing investor attention with its impressive potential upside of 118.51%. As a healthcare service provider..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Gem with 125% Upside Potential

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a promising player in the biotechnology sector, is making waves with its innovative approach to cancer treatment. With a market capitalization..

Cronos Group Inc. (CRON) Stock Analysis: Can This Cannabis Player Overcome a -17.12% Potential Downside?

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has captured the attention of investors with its diverse product line that includes dried..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: A 146% Upside Beckons in the Biotech Frontier

For individual investors with a penchant for the biotechnology sector, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents a compelling investment opportunity. With a potential upside of 146.39%..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 53.61% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its substantial potential..

Avanos Medical, Inc. (AVNS) Stock Analysis: Understanding the Healthcare Innovator’s Future Prospects

Avanos Medical, Inc. (NASDAQ: AVNS), a prominent player in the medical devices industry, is making waves with its innovative healthcare solutions. With a market capitalization of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds